Lachlan Brown
Stock Analyst
(n/a)
# 4,648
Out of 4,653 analysts
4
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lachlan Brown
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
APLS Apellis Pharmaceuticals | Initiates: Outperform | n/a | $29.26 | - | 1 | Oct 16, 2024 | |
DSGX The Descartes Systems Group | Initiates: Neutral | $90 | $115.17 | -21.85% | 1 | May 14, 2024 | |
MANH Manhattan Associates | Initiates: Buy | $260 | $284.34 | -8.56% | 1 | May 14, 2024 | |
SPSC SPS Commerce | Initiates: Buy | $220 | $186.77 | +17.79% | 1 | May 14, 2024 |
Apellis Pharmaceuticals
Oct 16, 2024
Initiates: Outperform
Price Target: n/a
Current: $29.26
Upside: -
The Descartes Systems Group
May 14, 2024
Initiates: Neutral
Price Target: $90
Current: $115.17
Upside: -21.85%
Manhattan Associates
May 14, 2024
Initiates: Buy
Price Target: $260
Current: $284.34
Upside: -8.56%
SPS Commerce
May 14, 2024
Initiates: Buy
Price Target: $220
Current: $186.77
Upside: +17.79%